oa Evaluation of the Demographics, Prevalence of Risk Factors and Treatment Strategies of Erectile Dysfunction in Qatar

References

1. Abdulbari B. Annual Statistical Report (2002) for health services provided in Qatar. Report from Ministry of Public Health & Hamad Medical Corporation. 2003;:117.
   [Google Scholar]
2. Hermann M, Berger P. Hormonal changes in aging men: A therapeutic indication? Exp Gerontol. 2001; 36::1075.
   [Google Scholar]
3. Schulman CC. The aging male: a challenge for urologists. Curr Opin Urol. 2000; 10::337.
   [Google Scholar]
4. Seyam RM, Albakry A, Ghobish A, Arif H, Dandash K, Rashwan H. Prevalence of erectile dysfunction and its correlates in Egypt: A community-based study. Int J Impot Res. 2003; 15::237.
   [Google Scholar]
5. Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res. 2003; 15::246.
   [Google Scholar]
6. Dunn KM, Croft PR, Hackett GI. Sexual problems: A study of the prevalence and need for health care in the general population. Fam Pract. 1998; 15::519.
   [Google Scholar]
7. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep. 2000; 2::189.
   [Google Scholar]
8. Verma KK, Khaitan BK, Singh OP. The frequency of sexual dysfunctions in patients attending a sex therapy clinic in north India. Arch Sex Behav. 1998; 27::309.
   [Google Scholar]
9. Virag R, Beck-Ardilly L. Nosology, epidemiology, clinical quantification of erectile dysfunctions. Rev Med Interne. 1997; 18:Suppl 1:10.
   [Google Scholar]
10. Dorey G. Is smoking a cause of erectile dysfunction? A literature review. Br J Nurs. 2001; 10::455.
    [Google Scholar]
11. Al Helali NS, Abolfotouh MA, Ghanem HM. Pattern of erectile dysfunction in Jeddah city. Saudi Med J. 2001; 22::34.
    [Google Scholar]
12. Bortolotti A, Fedele D, Chatenoud L, Colli E, Coscelli C, Landoni M, Lavezzari M, Santeusanio F, Parazzini F. Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur Urol. 2001; 40::392.
    [Google Scholar]
13. Braun M, Sommer F, Lehmacher W, Raible A, Bondarenko B, Engelmann U. [Erectile dysfunction]. Dtsch Med Wochenschr. 2004; 129::131.
    [Google Scholar]
14. Sanchez de la Vega J, Amaya Gutierrez J, Alonso Flores JJ, Garcia Perez M. Erectile dysfunction in those under 40. Etiological and contributing factors. Arch Esp Urol. 2003; 56::161.
    [Google Scholar]
15. Roth A, Kalter-Leibovici O, Kerbis Y, Tenenbaum-Koren E, Chen J, Sobol T, Raz I. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men. Clin Cardiol. 2003; 26::25.
    [Google Scholar]
16. Margolis SACT, Dunn EV, Reed RL. The health status of community based elderly in the United Arab Emirates. Arch Gerontol Geriatr. 2003; 37::1.
    [Google Scholar]
17. Nehra A. Treatment of endocrinologic male sexual dysfunction. Mayo Clin Proc. 2000; 75::S40.
    [Google Scholar]
18. Bodie J, Lewis J, Schow D, Monga M. Laboratory evaluations of erectile dysfunction: an evidence based approach. J Urol. 2003; 169::2262.
    [Google Scholar]
19. Earle CM, Stuckey BG. Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy? Urology. 2003; 62::727.
    [Google Scholar]
20. De la Torre Holguera P, Hernandez J, over D, Marti Malet J, Ochoteco Garcia J I. Assessment of erectile dysfunction with Doppler-duplex ultrasonography. Arch Esp Urol. 2001; 54::617.
    [Google Scholar]
21. Abdel-Hamid IA, Eraky I, Fouda MA, Mansour OE. Role of penile vascular insufficiency in erectile dysfunction in renal transplant recipients. Int J Impot Res. 2002; 14::32.
    [Google Scholar]
22. Gresser U, Gleiter CH. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil—review of the literature. Eur J Med Res. 2002; 7::435.
    [Google Scholar]
23. Tsujimura A, Yamanaka M, Takahashi T, Miura H, Nishimura K, Koga M, Iwasa A, Takeyama M, Matsumiya K, Takahara S, Okuyama A. The clinical studies of sildenafil for the ageing male. Int J Androl. 2002; 25::28.
    [Google Scholar]
24. Amar E, Kobelinsky M, Khoury R, Sarkis P, Bouyer I, Dauphin A, Delmas V, Boccon-Gibod L. Treatment of sexual impotency by intra-cavernous injections of prostaglandin El. Report of 180 patients. Prog Urol. 1993; 3::971.
    [Google Scholar]
25. Tan HL. Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. Pharmacoeconomics. 2000; 17::77.
    [Google Scholar]